Trafalgar International (GCAN) EPS (Diluted) Growth (3y) (2025 - 2026)

Trafalgar International (GCAN) EPS (Diluted) Growth (3y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EPS (Diluted) Growth (3y) (Qtr)
1	Haleon	44.07 Bn	43.10 Bn	-	-
2	Teva Pharmaceutical Industries	43.41 Bn	39.75 Bn	2.15 Bn	15.17%
3	Zoetis	31.83 Bn	30.15 Bn	1.05 Bn	3.25%
4	Takeda Pharmaceutical	28.77 Bn	22.97 Bn	5.10 Bn	2.66%
5	United Therapeutics	22.27 Bn	19.61 Bn	683.80 Mn	11.56%
6	Viatris	18.76 Bn	17.87 Bn	1.46 Bn	-35.09%
7	Neurocrine Biosciences	15.65 Bn	15.26 Bn	935.80 Mn	13.29%
8	Elanco Animal Health	11.93 Bn	11.40 Bn	798.00 Mn	36.48%
9	Dr Reddys Laboratories	10.16 Bn	10.00 Bn	-	-
10	Trafalgar International	236,233.75	236,233.75	-	-

Download Data